Anhydrous cefdinir (AC) vs. monohydrated cefdinir (MHC) was compared in order to be used as antimicrobial in therapeutics. Different techniques have been used to characterize physically AC and MHC, and also a complete microstructural analysis of raw materials was carried out. Cefdinir and Maltodextrin QDM (R) 500 (3:2) formulations were compressed in order to obtain tablets with typical dose of Cefdinir, i.e. 300 mg. Dissolution profiles were obtained for both AC and MHC tablets. Finally tablet X-ray diffraction was performed to ensure the stability of the monohydrated form after tabletting being clearly different in both AC and MHC crystals. AC crystal structure was agreed with the known pattern of anhydrous Cefdinir described in the literature. Microstructural analysis showed large differences in specific surface area (SSA), confirmed by mercury intrusion. Crystal structures of both AC and MHC were stable under mixing, compression and storing processes. Dissolution profiles were faster for hydrate form, probably related to microstructural properties of the crystal which remained after tabletting. In conclusion, it is possible to isolate Cefdinir in two forms anhydrous and monohydrate, well characterized and differentiated. The use of this later improves dissolution of tablet dosage form due to the lack of interconversion during tablet manufacture. (c) 2006 Elsevier B.V. All rights reserved.

Cabri W, Ghetti P, Alpegiani M, Pozzi G, Justo-Erbez A, Perez-Martinez JI, et al. (2006). Cefdinir: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 64(2), 212-221 [10.1016/j.ejpb.2006.05.007].

Cefdinir: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour

Cabri W;
2006

Abstract

Anhydrous cefdinir (AC) vs. monohydrated cefdinir (MHC) was compared in order to be used as antimicrobial in therapeutics. Different techniques have been used to characterize physically AC and MHC, and also a complete microstructural analysis of raw materials was carried out. Cefdinir and Maltodextrin QDM (R) 500 (3:2) formulations were compressed in order to obtain tablets with typical dose of Cefdinir, i.e. 300 mg. Dissolution profiles were obtained for both AC and MHC tablets. Finally tablet X-ray diffraction was performed to ensure the stability of the monohydrated form after tabletting being clearly different in both AC and MHC crystals. AC crystal structure was agreed with the known pattern of anhydrous Cefdinir described in the literature. Microstructural analysis showed large differences in specific surface area (SSA), confirmed by mercury intrusion. Crystal structures of both AC and MHC were stable under mixing, compression and storing processes. Dissolution profiles were faster for hydrate form, probably related to microstructural properties of the crystal which remained after tabletting. In conclusion, it is possible to isolate Cefdinir in two forms anhydrous and monohydrate, well characterized and differentiated. The use of this later improves dissolution of tablet dosage form due to the lack of interconversion during tablet manufacture. (c) 2006 Elsevier B.V. All rights reserved.
2006
Cabri W, Ghetti P, Alpegiani M, Pozzi G, Justo-Erbez A, Perez-Martinez JI, et al. (2006). Cefdinir: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 64(2), 212-221 [10.1016/j.ejpb.2006.05.007].
Cabri W; Ghetti P; Alpegiani M; Pozzi G; Justo-Erbez A; Perez-Martinez JI; Villalon-Rubio R; Monedero-Perales MC; Munoz-Ruiz A
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/756828
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 17
social impact